Masimo Corporation (MASI)Healthcare | Medical Devices | Irvine, United States |
USD
|
Hot Take ↕ | Aug. 22, 2026, 8:50 a.m. UTC
The short-term outlook is a definitive buy signal driven entirely by the completed acquisition by Danaher. The stock has surged 34% in a week as the deal closed at $180 per share in cash, effectively capping upside while eliminating downside risk for shareholders who now receive the full purchase price. With the price trading at exactly the target mean of $180 and the transaction finalized, the immediate investment thesis is to capture the remaining cash value before delisting mechanics take effect. However, the long-term investment case is neutral because the entity itself no longer exists as an independent public company. The multi-year price trajectory data is absent, reflecting the fact that the stock is being removed from the Nasdaq rather than continuing its historical path. There is no future revenue growth, ROE, or balance sheet quality to evaluate for a holding period beyond the delisting date, as the business will become a private subsidiary of Danaher. Finally, there is no dividend yield to consider. The recent five-year history shows no payouts, and the acquisition structure involves a cash payment rather than a dividend recapitalization. Investors seeking income will find nothing here. |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Ex Dividend Date | 2012-11-23 |
| Debt to Equity Ratio | 61.592 |
| Revenue per Share | 29.323 |
| Market Cap | 9,423,817,728 |
| Trailing P/E | 44.43 |
| Forward P/E | 26.87 |
| Beta | 1.10 |
| Profit Margins | 4.90% |
| Website | https://www.masimo.com |
| Attribute | Value |
|---|---|
| 52 Week Change | 0.10554767 |
| Address1 | 52 Discovery |
| All Time High | 305.21 |
| All Time Low | 17.62 |
| Ask | 194.36 |
| Ask Size | 100 |
| Audit Risk | 10 |
| Average Daily Volume10 Day | 854,373 |
| Average Volume | 946,426 |
| Average Volume10Days | 854,373 |
| Beta | 1.098 |
| Bid | 165.59 |
| Bid Size | 100 |
| Board Risk | 2 |
| Book Value | 15.065 |
| City | Irvine |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Compensation Risk | 6 |
| Country | United States |
| Currency | USD |
| Current Price | 179.95 |
| Current Ratio | 2.675 |
| Date Short Interest | 1,780,012,800 |
| Day High | 179.99 |
| Day Low | 179.95 |
| Debt To Equity | 61.592 |
| Ebitda | 367,700,000 |
| Ebitda Margins | 0.23593001 |
| Enterprise To Ebitda | 26.61 |
| Enterprise To Revenue | 6.278 |
| Enterprise Value | 9,784,526,848 |
| Ex Dividend Date | 1,353,628,800 |
| Exchange | NGM |
| Exchange Timezone Name | UTC |
| Fax | 949 297 7001 |
| Fifty Day Average | 178.6867 |
| Fifty Two Week High | 179.99 |
| Fifty Two Week Low | 125.94 |
| Financial Currency | USD |
| First Trade Date Epoch Utc | 1,781,098,200 |
| Float Shares | 44,306,186 |
| Forward Eps | 6.705 |
| Forward P E | 26.871563 |
| Free Cashflow | 327,924,992 |
| Full Time Employees | 2,200 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,780,531,200 |
| Gross Margins | 0.6163 |
| Gross Profits | 960,499,968 |
| Held Percent Insiders | 0.06215 |
| Held Percent Institutions | 1.04782 |
| Implied Shares Outstanding | 52,369,086 |
| Industry | Medical Devices |
| Industry Disp | Medical Devices |
| Industry Key | medical-devices |
| Last Fiscal Year End | 1,767,398,400 |
| Long Business Summary | Masimo Corporation engages in the development, manufacture, and marketing of various patient monitoring technologies, and automation and connectivity solutions worldwide. It offers Masimo Signal Extraction Technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo Rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of oxygen, carboxyhemoglobin, and methemoglobin. It also provides brain function and hemodynamic monitoring solutions; patient position and activity tracking, and neuromodulation technology solutions; and Masimo Hospital Automation platform, including hospital automation solutions, including Patient SafetyNet, Iris, iSirona, Replica, and UniView; and brain function monitoring, hemodynamic monitoring, regional oximetry, acoustic respiration rate monitoring, capnography and gas monitoring, and telehealth solutions. In addition, the company provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers. Masimo Corporation was incorporated in 1989 and is headquartered in Irvine, California. |
| Long Name | Masimo Corporation |
| Market Cap | 9,423,817,728 |
| Max Age | 86,400 |
| Message Board Id | finmb_31167 |
| Most Recent Quarter | 1,775,260,800 |
| Net Income To Common | 216,800,000 |
| Next Fiscal Year End | 1,798,934,400 |
| Number Of Analyst Opinions | 3 |
| Open | 179.95 |
| Operating Cashflow | 232,000,000 |
| Operating Margins | 0.23612 |
| Overall Risk | 4 |
| Payout Ratio | 0.0 |
| Peg Ratio | 4.83 |
| Phone | 949 297 7000 |
| Previous Close | 0.0 |
| Price Hint | 2 |
| Price To Book | 11.944905 |
| Price To Sales Trailing12 Months | 6.046723 |
| Profit Margins | 0.04896 |
| Quick Ratio | 1.271 |
| Quote Type | EQUITY |
| Recommendation Key | hold |
| Recommendation Mean | 3.0 |
| Regular Market Day High | 179.99 |
| Regular Market Day Low | 179.95 |
| Regular Market Open | 179.95 |
| Regular Market Previous Close | 0.0 |
| Regular Market Volume | 3,089,485 |
| Return On Assets | 0.10198 |
| Return On Equity | 0.24987 |
| Revenue Growth | 0.085 |
| Revenue Per Share | 29.323 |
| Sand P52 Week Change | 0.19895875 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 4 |
| Shares Outstanding | 52,369,086 |
| Shares Percent Shares Out | 0.0669 |
| Shares Short | 3,501,739 |
| Shares Short Previous Month Date | 1,777,507,200 |
| Shares Short Prior Month | 3,884,472 |
| Short Name | Masimo Corporation |
| Short Percent Of Float | 0.0734 |
| Short Ratio | 3.84 |
| State | CA |
| Symbol | MASI |
| Target High Price | 180.0 |
| Target Low Price | 180.0 |
| Target Mean Price | 180.0 |
| Target Median Price | 180.0 |
| Time Zone Full Name | America/New_York |
| Time Zone Short Name | EDT |
| Total Cash | 124,600,000 |
| Total Cash Per Share | 2.379 |
| Total Debt | 485,900,000 |
| Total Revenue | 1,558,499,968 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | NaN |
| Trailing Eps | 4.05 |
| Trailing P E | 44.432095 |
| Trailing Peg Ratio | None |
| Two Hundred Day Average | 156.65875 |
| Underlying Symbol | MASI |
| Uuid | e632c796-2b7c-370d-8fe5-85eca27f2bf0 |
| Volume | 3,089,485 |
| Website | https://www.masimo.com |
| Zip | 92,618 |